OrthoPediatrics Corp. (KIDS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 26.23 |
| Open | 26.23 |
| Day High | 26.23 |
| Day Low | 25.23 |
| 52-Week High | 26.74 |
| 52-Week Low | 14.42 |
| Volume | 364,624 |
| Average Volume | 180,940 |
| Market Cap | 658.82M |
| PE | -21.74 |
| EPS | -1.18 |
| Moving Average 50 Days | 20.79 |
| Moving Average 200 Days | 18.2 |
| Change | -0.58 |
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
GlobeNewswire Inc.
Feb 03, 2026 12:05 PM GMT
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and olderWARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Co
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
GlobeNewswire Inc.
Jan 12, 2026 12:05 PM GMT
Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”